Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy

DOI: 10.1080/2162402X.2016.1265717

Keywords: CD40 ligand, dendritic cells, oncolytic adenovirus, T-cells, tumor microenvironment

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text